For the quarter ending 2025-09-30.
| Income Statement | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Rent expense | - | 0 | 75* | - |
| Revenue | - | 0 | - | - |
| General and administrative expense | 5,872 | 5,469 | 871* | 9,467 |
| Professional and consulting fees | 4,203 | 4,950 | 12,199.5* | 7,950 |
| Total operating expenses | 10,075 | 10,419 | 13,145.5 | 17,417 |
| Operating loss | -10,075 | -10,419 | -13,145.5* | -17,417 |
| Interest expense | 1,891 | 1,246 | 1,253.5 | 1,260 |
| Total other income (expense) | -1,891 | -1,246 | -1,253.5* | -1,260 |
| Net loss before income tax | -11,966 | -11,665 | -14,399 | -18,677 |
| Income tax expense | - | 0 | - | - |
| Net loss | -11,966 | -11,665 | -14,399 | -18,677 |
| Basic EPS | 0 | 0 | -0 | 0 |
| Diluted EPS | 0 | 0 | -0 | 0 |
| Basic Average Shares | 83,548,469 | 83,548,469 | 87,948,469 | 81,348,469 |
| Diluted Average Shares | 83,548,469 | 83,548,469 | 87,948,469 | 81,348,469 |
Nu-Med Plus, Inc. (NUMD)
Nu-Med Plus, Inc. (NUMD)